| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA5225361 | F | In vivo antitumor activity against human SU-DHL-6 cells xenografted in NOD-SCID mouse model assessed as tumor growth inhibition at 25 mg/kg, po once daily for 18 to 21 days | Homo sapiens | 1 | ALA5223150 | organism-based format | Scientific Literature | |
| 2. | ALA5225365 | B | Inhibition of human PI3Kalpha in presence of [p32-gamma]-ATP measured after 2 hrs by hotspot assay | Homo sapiens | 2 | ALA5223150 | single protein format | Scientific Literature | |
| 3. | ALA5225366 | B | Inhibition of human PI3Kbeta in presence of [p32-gamma]-ATP measured after 2 hrs by hotspot assay | Homo sapiens | 2 | ALA5223150 | single protein format | Scientific Literature | |
| 4. | ALA5225367 | B | Inhibition of human PI3Kdelta in presence of [p32-gamma]-ATP measured after 2 hrs by hotspot assay | Homo sapiens | 2 | ALA5223150 | single protein format | Scientific Literature | |
| 5. | ALA5225368 | B | Inhibition of human PI3Kgamma in presence of [p32-gamma]-ATP measured after 2 hrs by hotspot assay | Homo sapiens | 2 | ALA5223150 | single protein format | Scientific Literature | |
| 6. | ALA5225369 | F | Antiproliferative activity against human JeKo-1 cells assessed as cell viability by non-radioactive cell proliferation MTT assay | Homo sapiens | 1 | ALA5223150 | cell-based format | Scientific Literature | |
| 7. | ALA5225370 | F | Antiproliferative activity against human WSUDLCL2 cells assessed as cell viability by non-radioactive cell proliferation MTT assay | Homo sapiens | 1 | ALA5223150 | cell-based format | Scientific Literature | |
| 8. | ALA5225371 | F | Antiproliferative activity against human SU-DHL-4 cells assessed as cell viability by non-radioactive cell proliferation MTT assay | Homo sapiens | 1 | ALA5223150 | cell-based format | Scientific Literature | |
| 9. | ALA5225372 | F | Antiproliferative activity against human SU-DHL-6 cells assessed as cell viability by non-radioactive cell proliferation MTT assay | Homo sapiens | 1 | ALA5223150 | cell-based format | Scientific Literature | |
| 10. | ALA5225373 | F | Antiproliferative activity against human OCILY3 cells assessed as cell viability by non-radioactive cell proliferation MTT assay | Homo sapiens | 1 | ALA5223150 | cell-based format | Scientific Literature | |
| 11. | ALA5225374 | F | Antiproliferative activity against human Granta-519 cells assessed as cell viability by non-radioactive cell proliferation MTT assay | Homo sapiens | 1 | ALA5223150 | cell-based format | Scientific Literature | |
| 12. | ALA5225375 | F | Antiproliferative activity against human NAMALVA cells assessed as cell viability by non-radioactive cell proliferation MTT assay | Homo sapiens | 1 | ALA5223150 | cell-based format | Scientific Literature | |
| 13. | ALA5225376 | F | In vivo antitumor activity against human JeKo-1 cells xenografted in NOD-SCID mouse model assessed as tumor growth inhibition at 25 mg/kg, po once daily for 18 to 21 days | Homo sapiens | 1 | ALA5223150 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!